| |
Univariate analysis |
Multivariate analysis* |
| |
OR (95% CI) |
p |
OR (95%CI) |
p |
| In-hospital death |
|
|
|
|
| Age, years |
1.07 (1,03-1,12) |
0,01 |
1.05 (1.001-1.11) |
0.05 |
| Male gender |
0.26 (0,11-0,67) |
0,01 |
0.26 (0.06-1.09) |
0.06 |
| Smoking |
0.53 (0,21-1,39) |
0,20 |
- |
|
| Reperfusion time, min |
1.00 (0.99-1.01) |
0,40 |
- |
|
| Left ventricular EF, % |
0.86 (0,82-0,91) |
0,01 |
0.95 (0,89-1.01) |
0.12 |
| Post-PCI TIMI flow <3 |
9.71 (2,48-38,1) |
0.01 |
3.32 (0.48-22.9) |
0.22 |
| Peak CK-MB (U/L) |
1.005 (1.003-1.007) |
0.01 |
1.006 (1.003-1.009) |
0.01 |
| Creatinine levels (mg/dL) |
10.7 (4,6-24,5) |
0.01 |
8.04 (2.9-22.2) |
0.01 |
| Hypertension / BP>130/85mmHg |
2.37 (0.90-6.21) |
0.08 |
1.58 (0.39-6.49) |
0.52 |
| Central obesity; WC >94 cm for men, > 80 cm for women |
1.57 (0.61 -4.1) |
0,35 |
- |
|
| DM / fasting glucose >100 mg/dL |
4.01 (0.91-17.6) |
0.07 |
2.58 (0.40 -9.55) |
0.32 |
| Triglycerides >150 mg/dL |
0.84 (0.31-2.20) |
0.73 |
- |
|
| HDL cholesterol; <40mg/dL for men, < 50mg/dL for women |
0.63 (0.23-1.65) |
0.37 |
- |
|
| Presence of metabolic syndrome |
1.95 (0.75-5.01) |
0.18 |
- |
|
| In-hospital MACE |
|
|
|
|
| Age, years |
1.04 (1.01-1.07) |
0,01 |
1.02 (0.99-1.05) |
0,21 |
| Male gender |
0.55 (0.24-1.27) |
0,16 |
- |
|
| Smoking |
1,17 (0.52-2.64) |
0,69 |
- |
|
| Reperfusion time, min |
1.00 (0.99-1.002) |
0.66 |
- |
|
| Left ventricular EF, % |
0.92 (0,88-0,96) |
0.01 |
0.97 (0.93-1.02) |
0,32 |
| Post-PCI TIMI flow <3 |
4.14 (1.18-16.4) |
0.03 |
2.04 (0.47-8.87) |
0,34 |
| Peak CK-MB , U/L |
1.003 (1.002-1.005) |
0.01 |
1.003 (1.001-1.005) |
0.01 |
| Creatinine , mg/dL |
7.61 (3.63-15.9) |
0,01 |
4.80 (2.18-9.96) |
0.01 |
| Hypertension / TA>130/85mmHg |
1.79 (0.90-3.55) |
0.09 |
1.36 (0.61-2.98) |
0.45 |
| Central obesity; >94 cm for men, > 80 cm for women |
0.90 (0.44-1.84) |
0,78 |
- |
|
| DM / fasting glucose >100 mg/dL |
3.11 (1.17-7.97) |
0.02 |
2.16 (0.78-5.97) |
0.14 |
| Triglycerides >150 mg/dL |
0.58 (0.28-1.21) |
0.17 |
- |
|
| HDL cholesterol <40mg/dL for men;< 50mg/dL for women |
1.07 (0.53-2.14) |
0.83 |
- |
|
| Presence of metabolic syndrome |
1.30 (0.65-2.57) |
0.45 |
- |
|
*Variables with p values <0.10 in univariate analyses were included in multivariate regression analysis. EF: Ejection Fraction, Post-PCI: Post-Primary Coronary Intervention,
BP: Blood Pressure, WC: Waist Circumference, DM: Diabetes Mellitus, HDL: High Density Lipoprotein |
